LISA RUDOLPH-WATSON: Open Payments
NPI 1881627867 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 18 payments from 7 companies in 2025. Trend: 2023 $135 · 2024 $160 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Axsome Therapeutics, Inc. | 1 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, COBENFY, Auvelity, CAPLYTA, AUSTEDO XR, REXULTI, FANAPT.
Industry payments across GA — which companies pay providers there.
